Tinnitus and Paget's disease of bone

Journal of Laryngology and Otology

Volumn 120, Issue 11, 2006, Pages 899-902

  Mackenzie, I ^a   Young, C ^b   Fraser, W D ^c  

^a LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Hearing loss; Paget's disease of bone; Tinnitus

Indexed keywords

ARTICLE; CONTROLLED STUDY; DISABILITY; FEMALE; HEALTH SURVEY; HEARING LOSS; HUMAN; MAJOR CLINICAL STUDY; MALE; PAGET BONE DISEASE; PREVALENCE; QUESTIONNAIRE; TINNITUS;

AGED; AUDIOMETRY; CASE-CONTROL STUDIES; ENGLAND; FEMALE; HEARING LOSS; HUMANS; MALE; OSTEITIS DEFORMANS; PREVALENCE; PROSPECTIVE STUDIES; TINNITUS;

EID: 33845265909     PISSN: 00222151     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0022215106002519     Document Type: Article

References (39)

1. Paget J. On a form of chronic inflammation of bones (osteitis deformans). Med Chir Trans 1877;60:37-64
2. Morales-Piga AA, Rey-Rey JS, Corres-Gonzalez J, Garcia-Sagredo JM, Lopez-Abente G. Frequency and characteristics of familial aggregation of Paget's disease of bone. J Bone Miner Res 1995;10:663-70
3. Siris ES, Ottman R, Flaster E, Kelsey JL. Familial aggregation of Paget's disease of bone. J Bone Miner Res 1991;6:495-500
4. Sofaer JA, Holloway SM, Emery AE. A family study of Paget's disease of bone. J Epidemiol Community Health 1983;37:226-31
5. Hocking LJ, Lucas GJ, Daroszewska A, Mangion J, Olavesen M, Cundy T et al. Domain specific mutations in sequestosome1 (SQSTM1) cause familial and sporadic Paget's disease. Hum Mol Genet 2002;11:2735-9
6. Johnson-Pais TL, Wisdom JH, Weldon KS, Cody JD, Hansen MF, Singor FR et al. Three novel mutations in SQSTM1 identified in familial Paget's disease of bone. J Bone Miner Res 2003;18:1748-53
7. Barker DJP, Clough PW. Paget's disease of bone in 14 British towns. Brit Med Bull 1977;40:396-400
8. Cooper C, Schafheutle K, Dennison Y, Kellingray S, Guyer P. The epidemiology of Paget's disease in Britain: is the prevalence decreasing? J Bone Miner Res 1999;14:192-7
9. Cundy HR, Gamble G, Wattie D, Rutland H, Cundy T. Paget's disease of bone in New Zealand: continued decline in disease severity. Calcif Tissue Int 2004;75:358-64
10. Gardner MJ, Barker DJP. Mortality from malignant tumours of bone and Paget's bone disease in the United States and in England and Wales. Int J Epidemiol 1978;7:121-30
11. Ooi CG, Fraser WD. Paget's disease of bone. Postgrad Med J 1997;73:69-74
12. Gold DT, Boisture J, Shipp KM, Pieper CF, Lyles KW. Paget's disease of bone and quality of life. J Bone Miner Res 1996;11:1897-904
13. Monsell EM, Cody DD, Bone HG, Divine GW. Hearing loss as a complication of Paget's disease of bone. J Bone Miner Res 1999;14(Suppl 1):92-5
14. Baraka ME. Rate of progression of hearing loss in Paget's disease. J Laryngol Otol 1984;98:573-5
15. Clemis JD, Boyles J, Harforder ER, Petasnick JP. The clinical diagnosis of Paget's disease of the temporal bone. Ann Otol Rhinol Laryngol 1967;76:611-23
16. Lindsay JR, Perlman HB. Paget's disease and deafness. Archives of Otolaryngology and Otology 1936;23:581-7
17. Sparrow NL, Duvall AJ. Hearing loss and Paget's disease. J Laryngol Otol 1967;81:601-11
18. Proops D, Bayley D, Hawke M. Paget's disease and the temporal bone - a clinical and histopathological review of six temporal bones. J Otolaryngol 1985;14:20-9
19. Nagar GT. Paget's disease of the temporal bone. Ann Otol Rhinol Laryngol 1975;84:1-31
20. Donath J, Krasznai M, Fornet B, Gorgely P, Poor G. Effect of biphosphonate treatment of patients with Paget's disease of the skull. J Rheumatol 2004;43:89-94
21. Singer FR. Clinical efficacy of salmon calcitonin in Paget's disease of bone. Calcif Tissue Int 1991;49(suppl 2):S7-8
22. Lando M, Hoover LA, Finerman G. Stabilisation of hearing loss in Paget's disease with calcitonin and etidronate. Arch Otol Head Neck Surg 1988;14:891-4
23. El Sammaa M, Linthicum FH, House HP, House HW. Calcitonin as treatment for hearing loss in Paget's disease of skull. Am J Otol 1986;7:241-3
24. Walker GS, Evanson JM, Canty DP, Gill NW. Effect of calcitonin in deafness due to Paget's disease of the skull. Arch Otol Head Neck Surg 19793:364-5
25. Solomon LR, Evanson JM, Canty DP, Gill NW. Effect of calcitonin treatment on deafness due to Paget's disease of the skull. Br Med J 1977;2:485-7
26. Perlmann HB. Sensori neural deafness. Arch Otolaryngol 1965;82:322-4
27. Collins DH, Winn JM. Focal Paget's disease of the skull (osteoporosis circumscripta). Journal of Pathology and Bacteriology 1955;69:1-9
28. Baguley DM, McFerran DJ. Current perspective on tinnitus. Arch Dis Child 2002;86:141-3
29. Axelsson A, Ringdahl A. Tinnitus - a study of its prevalence and characteristics. Br J Audiol 1989;23:53-62
30. Quaranta A, Assennato G, Sallustio V. Epidemiology of hearing problems among adults in Italy. Scand Audiol Suppl 1996;42:9-13
31. Davis AC, Rafaie EA. Epidemiology of tinnitus. In: Tyler RS, ed. Tinnitus Handbook. San Diego, CA: Singular Press, 2000;1-24
32. Sataloff J, Sataloff RT, Lueneburg W. Tinnitus and vertigo in healthy senior citizens without a history of noise exposure. Am J Otol 1987;8:87-9
33. Ventry IM, Weinstein BE. The hearing handicap inventory for the elderly: a new tool. Ear Hear 1982;3:128-134
34. Lichtenstein MJ, Bess FH, Logan SA. Validation of screening tools for identifying hearing unpaired elderly in primary care. JAMA 1988;159:2875-8
35. Jastreboff PJ, Gray WC, Gold SL. Neurophysiological approach to tinnitus patients. Am J Otol 1996;17:236-40
36. Stephens D, Kerr P. Auditory disablements: an update. Audiology 2000;39:322-32
37. Sahley TL, Nodar RH. A biochemical model of peripheral tinnitus. Hear Res 2001;152:43-54
38. Simpson J, Davis W. A review of evidence in support of a role for 5HT in perception of tinnitus. Hear Res 2000;145:1-7
39. Sullivan M, Katon W, Russo J, Dobie R, Sakai C. A randomized trial of nortriptyline for severe chronic tinnitus. Effects on depression, disability, and tinnitus symptoms. Arch Intern Med 1993;153:2251-9